| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
10,025 |
8,650 |
$598K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
3,435 |
3,309 |
$260K |
| 80053 |
Comprehensive metabolic panel |
46,712 |
29,619 |
$239K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
7,091 |
6,161 |
$170K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
55,042 |
32,264 |
$160K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,873 |
3,595 |
$137K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
14,618 |
13,636 |
$114K |
| 83735 |
|
24,372 |
12,070 |
$90K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
20,724 |
8,395 |
$87K |
| 84484 |
|
12,874 |
9,770 |
$56K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
8,608 |
7,951 |
$46K |
| 87040 |
|
4,738 |
3,766 |
$45K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,123 |
4,609 |
$43K |
| 83880 |
|
3,264 |
2,509 |
$39K |
| 87081 |
|
13,111 |
12,190 |
$38K |
| 83690 |
|
10,230 |
8,475 |
$36K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,646 |
1,579 |
$36K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,639 |
1,572 |
$36K |
| 85027 |
|
11,474 |
5,568 |
$33K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,586 |
1,559 |
$33K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,140 |
923 |
$31K |
| 83605 |
|
5,505 |
4,047 |
$27K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,057 |
1,026 |
$26K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,098 |
2,827 |
$25K |
| 88342 |
|
1,546 |
1,440 |
$24K |
| 84100 |
|
9,044 |
2,906 |
$21K |
| 85730 |
|
6,448 |
4,660 |
$21K |
| 0240U |
|
239 |
237 |
$18K |
| 85610 |
|
8,263 |
5,578 |
$17K |
| 81001 |
|
11,112 |
10,022 |
$16K |
| 86850 |
|
4,453 |
3,839 |
$13K |
| 85379 |
|
3,256 |
2,375 |
$13K |
| 86901 |
|
5,689 |
4,915 |
$12K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
329 |
329 |
$12K |
| 86900 |
|
5,686 |
4,913 |
$9K |
| 80061 |
Lipid panel |
2,387 |
2,172 |
$9K |
| 88307 |
|
135 |
119 |
$9K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
250 |
243 |
$9K |
| 82803 |
|
749 |
702 |
$8K |
| 82550 |
|
2,623 |
1,701 |
$8K |
| 88304 |
|
436 |
424 |
$8K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
47 |
42 |
$8K |
| 87088 |
|
1,362 |
1,305 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,379 |
2,152 |
$7K |
| 84702 |
|
1,593 |
1,353 |
$7K |
| 84439 |
|
1,550 |
1,413 |
$7K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
469 |
458 |
$7K |
| 86140 |
|
2,816 |
2,120 |
$7K |
| 87075 |
|
889 |
764 |
$6K |
| 82728 |
|
1,208 |
734 |
$5K |
| 82077 |
|
356 |
325 |
$5K |
| 87070 |
|
1,449 |
1,214 |
$5K |
| 87480 |
|
367 |
346 |
$5K |
| 87510 |
|
367 |
346 |
$5K |
| 81003 |
|
4,503 |
4,170 |
$5K |
| 85018 |
|
3,085 |
1,689 |
$4K |
| 87563 |
|
324 |
316 |
$4K |
| 87660 |
|
366 |
345 |
$3K |
| 87205 |
|
1,639 |
1,333 |
$3K |
| 80143 |
|
171 |
161 |
$3K |
| 82140 |
|
629 |
296 |
$3K |
| 82607 |
|
469 |
421 |
$3K |
| 80179 |
|
164 |
154 |
$3K |
| 83615 |
|
909 |
512 |
$3K |
| 82570 |
|
951 |
799 |
$2K |
| 84703 |
|
605 |
590 |
$2K |
| 85652 |
|
1,561 |
1,378 |
$2K |
| 87641 |
|
80 |
72 |
$2K |
| 86480 |
|
74 |
71 |
$2K |
| 85014 |
|
1,505 |
1,207 |
$2K |
| 83550 |
|
399 |
361 |
$2K |
| 81025 |
|
641 |
606 |
$2K |
| 87340 |
|
256 |
229 |
$2K |
| 82746 |
|
278 |
250 |
$2K |
| 80076 |
|
323 |
279 |
$1K |
| 82248 |
|
602 |
430 |
$1K |
| 82010 |
|
453 |
335 |
$1K |
| 82247 |
|
484 |
270 |
$1K |
| 84300 |
|
458 |
391 |
$962.48 |
| 84145 |
|
353 |
197 |
$936.05 |
| 80202 |
|
132 |
80 |
$889.76 |
| 85049 |
|
702 |
199 |
$840.28 |
| 84156 |
|
678 |
570 |
$790.12 |
| 86880 |
|
269 |
261 |
$782.50 |
| 85048 |
|
892 |
267 |
$766.19 |
| 88112 |
|
53 |
47 |
$717.38 |
| 87493 |
|
31 |
29 |
$710.21 |
| 84132 |
|
271 |
223 |
$621.24 |
| 87807 |
|
121 |
118 |
$593.54 |
| 80050 |
General health panel |
32 |
15 |
$509.25 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
17 |
17 |
$417.69 |
| 87210 |
|
155 |
155 |
$361.90 |
| 86706 |
|
53 |
51 |
$323.25 |
| 86592 |
|
144 |
143 |
$284.70 |
| 83935 |
|
109 |
92 |
$257.69 |
| 80074 |
|
13 |
13 |
$250.12 |
| 87806 |
|
26 |
26 |
$233.82 |
| 80320 |
|
660 |
481 |
$180.00 |
| 89051 |
|
59 |
41 |
$171.50 |
| 83930 |
|
65 |
51 |
$163.10 |
| 86308 |
|
65 |
65 |
$148.80 |
| 82150 |
|
43 |
37 |
$137.17 |
| 84550 |
|
59 |
42 |
$121.67 |
| 86803 |
|
13 |
13 |
$109.46 |
| 87147 |
|
54 |
53 |
$95.95 |
| 86038 |
|
13 |
12 |
$78.65 |
| 86704 |
|
12 |
12 |
$72.36 |
| 87077 |
|
170 |
148 |
$25.86 |
| 84157 |
|
14 |
12 |
$19.40 |
| 80329 |
|
313 |
245 |
$0.00 |